These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 6242101)
1. [Use of homologous vaccine in Pseudomonas aeruginosa infection of the urinary tract in rats]. Sprogis J Ann Acad Med Stetin; 1984; 30():371-84. PubMed ID: 6242101 [No Abstract] [Full Text] [Related]
2. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity. Sabharwal N; Chhibber S; Harjai K Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605 [TBL] [Abstract][Full Text] [Related]
3. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003). Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722 [TBL] [Abstract][Full Text] [Related]
4. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. Mittal R; Sharma S; Chhibber S; Harjai K J Biomed Sci; 2008 Nov; 15(6):731-41. PubMed ID: 18688758 [TBL] [Abstract][Full Text] [Related]
5. Community-acquired Pseudomonas aeruginosa urinary tract infection in young children. Mocan H; Karagüzel G Pediatr Nephrol; 1997 Dec; 11(6):784-5. PubMed ID: 9438666 [No Abstract] [Full Text] [Related]
6. [Immunomodulation in Pseudomonas urinary infection]. Urban M; Tamele L Rozhl Chir; 1995 Nov; 74(7):319-21. PubMed ID: 8629153 [TBL] [Abstract][Full Text] [Related]
7. The response of the renal pelvis to infection: a scanning electron microscopic study. Cohen MS; Davis CP; Warren MM Invest Urol; 1979 Mar; 16(5):360-4. PubMed ID: 429132 [TBL] [Abstract][Full Text] [Related]
8. Enhanced immune response in "R" inbred rats by chemical and/or bacterial immunostimulation. I. Protection induced by Aerodin and Bronhodin associated or not with levamisole against experimental infection with Pseudomonas aeruginosa or grafting HR18 tumoral cells. Popescu C; Pencea I; Hoişie S; Economu D; Anton D; Grecu V; Scorţea D; Pop I Arch Roum Pathol Exp Microbiol; 1985; 44(1):43-53. PubMed ID: 3929748 [No Abstract] [Full Text] [Related]
9. Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria. Neagu V; Meitert E; Ioanid CP; Racovită C; Găleşanu M; Sima F; Savulian C; Momiceanu D; Noica N; Neagoe M Arch Roum Pathol Exp Microbiol; 1984; 43(1):39-52. PubMed ID: 6442131 [No Abstract] [Full Text] [Related]
10. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa. Cachia PJ; Hodges RS Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116 [TBL] [Abstract][Full Text] [Related]
11. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa]. Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310 [No Abstract] [Full Text] [Related]